WaferGen Files for $40M Public Offering; Seeks Move to Nasdaq | GenomeWeb

NEW YORK (GenomeWeb) – WaferGen Biosystems has filed with regulators to offer up to $40 million of its common stock.

In its Form S-1 filed recently with the US Securities and Exchange Commission, the company also said that it has applied with the Nasdaq to list its common shares on the Nasdaq Capital Market under ticker symbol "WGBS." The company said that it expects the Nasdaq listing to occur upon consummation of the $40 million offering. WaferGen currently lists its stock on the OTCQB Marketplace.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: modern European bison analysis, phased diploid genome assembly algorithms, and more.

Actress Jennifer Lopez is working with NBC on a CRISPR-inspired television show, according to the Hollywood Reporter.

Researchers trace the origin of one human papillomavirus lineage to Neanderthals or Denisovans, Vox reports.

The BabySeq project faces lower-than-expected enrollment rates, according to ScienceInsider.